Evaluation of clinical and functional sequels of central serous chorioretinopathy. A case series analysis.

Autor: Cerón Enríquez AM; Universidad del Sinú, Clínica Oftalmológica de Cartagena, Cartagena, Colombia. Electronic address: amceronenriquez@gmail.com., Teherán Forero OL; Departamento de Glaucoma, Clínica Oftalmológica de Cartagena, Cartagena, Colombia., Atencia Niño C; Departamento de Retina y Vítreo, Clínica Ebenezer, Cartagena, Colombia., Almanza Benito Revollo R; Departamento de Retina y Vítreo, Clínica Oftalmológica de Cartagena, Cartagena, Colombia., Ramos Clason EC; Grupo de investigación GIBACUS, Escuela de Medicina, Universidad del Sinú, Seccional Cartagena, Cartagena, Colombia., Ochoa Díaz MM; Grupo de investigación GIBACUS, Escuela de Medicina, Universidad del Sinú, Seccional Cartagena, Cartagena, Colombia.
Jazyk: angličtina
Zdroj: Archivos de la Sociedad Espanola de Oftalmologia [Arch Soc Esp Oftalmol (Engl Ed)] 2022 Nov; Vol. 97 (11), pp. 612-619. Date of Electronic Publication: 2022 Jul 22.
DOI: 10.1016/j.oftale.2022.06.010
Abstrakt: Objective: To evaluate the clinical and functional sequelae of patients with a diagnosis of resolved CSC, through macular OCT, contrast sensitivity test, visual field 10-2 and Farnsworth D-15 color test.
Methods: 27 eyes of 26 individuals with CSC resolved by macular OCT were included and evaluated; the patients underwent a contrast sensitivity test with the Optec 6500 equipment, a 10-2 visual field with an Octopus 900 Haag-Streit, and a Farnsworth D-15 color test.
Results: Sequelae were observed in 20 eyes (74.1%) by macular OCT and in 21 (77.8%) in contrast sensitivity, predominantly type 2 defect. Also 27 (100%) had a visual field 10-2 altered corresponding to reduced foveal sensitivity, 11 eyes (40.7%) corresponded to central and paracentral scotomas. The color test showed alteration in 11 (40.7%) of the total eyes evaluated, finding tritanomaly in 9 of them (81.8%). No significant differences were observed in the studies between observation group vs the treatment group.
Conclusions: CSC can leave sequelae in the visual quality of patients despite treatment in the acute phase. Visual acuity before and after treatment in the intervention group had no significant difference.
(Copyright © 2022 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: